SWOT Analysis for Gossamer Bio Inc

Positive Breakout First Resistance ( LTP > R1)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over the Quarter (3 Months)
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Positive Breakout (LTP > R1)
Top Gainers
Stocks in uptrend most likely to cross above SMA-200 soon
Stock with Low PE (PE < = 10)

Momentum Trap (DVM)
Companies with High Debt
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Companies with Increasing Debt
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Declining profits every quarter for the past 2 quarters
Declining Revenue every quarter for the past 2 quarters
RSI indicating price weakness